Is Cullinan Therapeutics, Inc. (CGEM) a Buy, Sell, or Hold?
NASDAQ : CGEM
Cullinan Therapeutics, Inc. — Analyst Ratings
$19.46 USD
$1.18 (6.46%)
- Volume
- 346.72K
- Average Volume
- 933.5K
- Market Capitalization
- $1.2B
- P/E Ratio
- -5.77
- Dividend Yield
- 0.00%
- Price Target
- $33.50
- Year High
- $19.55
- Year Low
- $5.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.42
Analyst Consensus Summary
Consensus Rating
Sell
8 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-41.9%
vs Current Price
Price Target
$33.50
Average TargetPrice Target Range
Lowest Target
$28.00
-30.5% DOWNSIDE
Average Target
$33.50
Median Estimate
Highest Target
$39.00
-50.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Robert Burns | $30 | $12.785 | 2026-04-28 12:01 PM | 134.6% |
| Stifel Nicolaus | Alex Thompson | $28 | $15.1061 | 2026-03-10 09:18 AM | 85.4% |
| Wedbush | Robert Driscoll | $34 | $12.18 | 2025-12-09 08:13 AM | 179.1% |
| BTIG | Julian Harrison | $38 | $11.9024 | 2025-11-24 11:42 AM | 219.3% |